One ex vivo study, performed by Durak et al., assessed the ability of UD to halt prostate cancer progression in prostate cancer tissue extracted from patients; the authors noted a significant inhibition of the adenosine deaminase (ADA) enzyme, involved in the elimination of the toxic deoxyinosine molecule. Here, ADA is linked to prostate carcinoma.